NCT05350774: An ongoing trial by National Institute of Neurological Disorders and Stroke (NINDS)
This trial is ongoing. It must report results 12 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05350774 |
|---|---|
| Title | Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 10, 2023 |
| Completion date | Dec. 15, 2025 |
| Required reporting date | Dec. 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |